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Genotype-Speciﬁc Pattern of
LV Involvement in ARVD/C
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ARRHYTHMOGENIC RIGHT VENTRICULARDYSPLASIA/CARDIOMYOPATHY (ARVD/C) is a clinically
heterogeneous cardiomyopathy caused by desmosomal mutations that may lead to ventricular arrhythmias
and sudden death (1). Among international studies describing structural phenotype in ARVD/C, signiﬁcant
iscrepancy exists regarding the pattern, extent, and incidence of left ventricular (LV) involvement (2). We
elieve genotype plays an important role in determining ARVD/C phenotype, and that the prevalence of
ifferent mutations in these studies explains the discrepancy. Predominant LV involvement is frequently
een in the context of a desmoplakin mutation, with ﬁbroadipose replacement in a LV circumferential,
id-myocardial pattern extending to the right side of the septum. Interestingly, in plakophilin-2 mutation
arriers, LV involvement is often focal and progressive LV dysfunction is very uncommon. In this iPIX, we
llustrate these distinct structural phenotypes in 2 deﬁnite ARVD/C patients harboring different pathogenic
utations (Figs. 1 and 2). Large-scale studies involving pooled international registries are needed to further
haracterize the genotype-phenotype relationship in ARVD/C.
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850Figure 1. Right Dominant ARVD/C
A 51-year-old man presented with multiple episodes of sustained ventricular
tachycardia of left bundle branch block morphology with exercise. Genetic
testing revealed an arrhythmogenic right ventricular dysplasia/cardiomyopathy
(ARVD/C)–associated pathogenic frameshift mutation in the plakophilin-2
gene (S50fsX110). (A) His ECG shows pre-cordial T-wave inversions up to V3
and frequent premature ventricular complexes. Axial (B and Online Video 1)
and short axis (C and Online Video 2) bright blood images show RV dilation
(RV EDV/BSA 147 ml/m2) with multiple RV free wall microaneurysms
(arrows) and fatty inﬁltration in the LV apicolateral region (arrowhead). RV
function is diminished (RV EF 38%) with dyskinesia of the RV basal free wall.
The LV has normal size (LV EDV/BSA 93 ml/m2) and function (LV EF 59%).
(D) T1-weighted image reveals moderate subepicardial fatty inﬁltration of
the RV free wall, extending as “ﬁngers” into the myocardium (arrows). Note
fatty inﬁltration in the LV apicolateral region (arrowhead). (E and F) Late
gadolinium enhancement images show RV subtricuspid and free wall
ﬁbrosis (arrows), without LV involvement. BSA  body surface area; ECG 
electrocardiogram; EDV  end-diastolic volume; EF  ejection fraction;
LV  left ventricular; RV  right ventricular.
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Figure 2. Left Dominant ARVD/C
A 47-year-old woman presented with recurrent episodes of
unexplained exertional syncope. Genetic testing identiﬁed an
ARVD/C–associated pathogenic nonsense mutation in the
desmoplakin gene (G51X). (A) Her ECG shows terminal activation
delay 55 ms in the right pre-cordial leads and T-wave inversion
throughout the pre-cordium. Axial (B and Online Video 3) and
short axis (C and Online Video 4) bright blood images show
moderate LV dilation (LV EDV/BSA 109 ml/m2) with multiple focal
areas of LV myocardial wall thinning. LV function is diminished
(EF 36%) with global hypokinesia, which is more pronounced in
the anterolateral wall. RV involvement is conﬁned to subtricuspid
dyskinesia (arrow). RV size (RV EDV/BSA 64 ml/m2) and function
(RV EF 51%) are normal. (D and E) Late gadolinium enhancement
images show extensive LV ﬁbrosis in a mid-myocardial pattern
involving the lateral and septal walls (arrows). There is no RV
delayed enhancement. Abbreviations as in Figure 1.2R E F E R E N C E S
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